The World Health Organization has released a list of emergency use of the COVID-19 vaccine made by Sinovac in adults aged 18 and over, the second such clearance it has granted to a Chinese company .
In a statement on Tuesday, the United Nations health agency said data submitted to its experts showed two doses of the vaccine were preventing people from showing symptoms of COVID-19 in about half of those who received the vaccine. vaccine. The WHO said few older adults were enrolled in the research, so it couldn’t estimate the vaccine’s effectiveness in people over 60.
“Nonetheless, the WHO does not recommend an upper age limit for the vaccine,” the agency said, adding that data collected on the use of Sinovac in other countries “suggests that the vaccine is likely to ‘have a protective effect in the elderly “.
WHO authorization means the vaccine can be purchased by donors and other UN agencies for use in poorer countries, including as part of the UN-backed initiative to distribute COVID-19 vaccines known worldwide as COVAX.
Last month, the WHO gave the green light to the COVID-19 vaccine made by Sinopharm. It has also licensed vaccines developed by Pfizer-BioNTech, Johnson & Johnson, Moderna Inc and AstraZeneca.
COVAX’s effort was significantly slowed down after its largest supplier in India said it would no longer be able to deliver vaccines before the end of the year.
To date, there is no confirmed agreement for the doses of Sinovac with COVAX.
MORE ON THE VIRUS EPIDEMIC:
– Peru dramatically increases COVID-19 death toll, up to more 180,000 compared to the previous count of nearly 70,000
– The grief of the son, the guilt becomes tribute tribute to the victims of COVID-19
– The vaccine surge in Japan before the Olympics seems to be too late
– Business closures Malaysia second lockdown as increase puts healthcare system on the brink of collapse
HERE’S WHAT ELSE HAPPENS:
LONDON – The UK government said no new coronavirus deaths were reported on Tuesday, the first time since July 2020.
The positive news came amid concerns over the increase in UK cases of the variant coronavirus first identified in India and uncertainty over whether authorities will move forward with the latest Steps to easing social restrictions later this month.
As of Tuesday, there had been 3,165 other confirmed cases of COVID-19 in the UK, up from around 2,500 cases last week. Parts of the North West of England have seen a sharp rise in infections. Officials said up to three-quarters of these new cases are the Indian variant, which they say appears to be more communicable.
Official figures showed that no deaths within 28 days of testing positive for the coronavirus were reported on Tuesday. The total death toll in the UK stood at 127,782, the highest in Europe.
WASHINGTON – Memorial Day weekend produced the two busiest days for air travel in the United States since early March 2020.
About 1.96 million people passed through security checkpoints at U.S. airports on Friday, and 1.90 million did so on Monday, according to the U.S. Transportation Security Administration.
Tuesday is also expected to be busy, with travelers returning home after Memorial Day weekend. Analysts expect travel to continue slowly increasing now that many Americans are vaccinated against COVID-19 and airlines are adding more flights.
In May, an average of 1.6 million people per day were screened at U.S. airports, a third less than the 2.4 million people per day who passed through TSA checkpoints in May 2019.
ALGIERS, Algeria – Algeria partially reopened its skies to flights on Tuesday after a 14-month shutdown in an attempt to maintain the coronavirus.
A first flight of the national company Air Algeria took off Tuesday for Paris and another was to land in Algiers, the capital.
Great caution has governed the reopening, with limited flights, testing for COVID-19 and mandatory quarantine. Those heading to Algiers must test negative less than 36 hours before boarding, and all passengers must undergo a five-day quarantine in a hotel requisitioned by the state.
A negative test result is required to leave the hotel.
GENEVA – The European Medicines Agency said it has recommended approving two additional manufacturing and finishing sites for the coronavirus vaccine made by Pfizer and BioNTech.
In a statement on Tuesday, the European medicines regulator said the additional vaccine production and filling sites were at the Pfizer plant in Puurs, Belgium. The EMA said its decision, based on a review of manufacturing data submitted by BioNTech, is expected to have “a significant and immediate impact” on the supply of the vaccine to the 27 EU countries by Pfizer and BioNTech.
Last month, the European Commission signed a third contract with Pfizer-BioNTech to obtain an additional 1.8 billion doses of their vaccine from 2021 to 2023. The contract stipulated that vaccine production would be based in the EU and that the delivery to the EU would be guaranteed in 2022. In April, the EU sued AstraZeneca for failing to meet the hundreds of millions of doses promised to Europe in its contract.
CAMBRIDGE, Mass. – U.S. pharmaceutical company Moderna has said it has started the process to gain full U.S. regulatory approval for the use of its COVID-19 vaccine in adults.
Moderna said on Tuesday it had started a “continuous submission” to the Food and Drug Administration of data from its two-dose vaccine studies.
Moderna’s vaccine has already been cleared for emergency use by the FDA and regulators in many other countries. So far, over 124 million doses have been administered in the United States.
Large-scale studies of the shots continued after Moderna’s emergency clearance. The FDA will review the information to see if the vaccine meets strict criteria for full approval.
Moderna is the second COVID-19 vaccine maker to achieve full approval, after Pfizer and its German partner BioNTech.
Last week, Moderna also announced that its vaccine appears safe and effective in children as young as 12. The company plans to apply for an emergency clearance for teens this month.
ISLAMABAD – Pakistani authorities on Tuesday launched a locally processed, locally-filled and packaged Chinese CanSino vaccine known as PakVac.
The development comes weeks after China supplied the bulk vaccine in concentrated form for filling and packaging to Pakistan.
The Chinese concentrate is processed, sterilized and packaged at a health facility in the capital, Islamabad, with a deployment capacity of three million doses per month.
In a speech at a ceremony, Pakistani Planning and Development Minister Asad Umar thanked China for helping Pakistan process, fill and package the vaccine locally.
The launch comes amid declining deaths and infections from the coronavirus.
Pakistan has recorded 20,850 deaths out of 922,824 confirmed cases of COVID-19 since last year.
NEW YORK – A play about young black men trapped on a street corner has positioned itself as the first Broadway show audiences can watch live when the Great White Way reboots.
Antoinette Chinonye Nwandu’s “Pass Over” show will begin on August 4 at the August Wilson Theater, several weeks before any other show.
Riffing from “Waiting for Godot,” the play is seemingly perfect for post-COVID-19 Broadway: just three actors and 85 minutes with no intermission.
The play was first performed in Chicago in 2017 and was filmed by Spike Lee. It was most recently produced at the Lincoln Center Off-Broadway Theater in 2018 and this cast will be making the jump to Broadway.
LANSING, Michigan – Michigan crossed a threshold in the COVID-19 pandemic on Tuesday with the lifting of certain restrictions at outdoor events and inside bars and restaurants.
Masks are no longer required outdoors and capacity limits are extinguished during sporting events and outdoor concerts.
Restaurants and bars may operate indoors at 50% capacity and may remain open after 11 p.m. There is no limit to the number of people at a table. Full capacity returns on July 1.
Governor Gretchen Whitmer announced the changes on May 20 as new coronavirus cases slowed and more Michigan residents were getting vaccinated against COVID-19.
There were only 445 new cases reported on Saturday, the latest figures available due to the Memorial Day holiday.
ROME – Italians can eat and drink indoors in bars and restaurants for the first time in months, and that includes the morning ritual of having an espresso or cappuccino at a local cafe.
Until Tuesday, companies were either to offer outdoor seating or serve coffee in take-out cups, urging customers to step away from the bar before sipping or encounter viral restrictions.
Rome resident Paolo Leoni enjoyed an espresso at Cafe Toraldo in central Rome. He said that “a coffee gives us the feeling of living serenely again”.
Cafe owner Alessandro Rappini said seeing the place fill up again after four months “gives me a tremendous sense of satisfaction.”
Italy began rolling back restrictions on the pandemic in April, with the number of new cases showing signs of steadily declining. To date, nearly 35 million people in the country of 60 million have received at least one injection of a COVID-19 vaccine.
BERLIN – German authorities are investigating allegations of fraud involving the massive deployment of free coronavirus tests, which are currently being carried out at converted cellphone stores, beauticians and art galleries across the country.
Germans must show a negative test result to enter non-essential stores, visit restaurants or bars, or attend small-scale cultural events. The government pays for one free test per person each week, which has led to a proliferation of more than 15,000 companies offering antigen tests that provide results within 20 minutes.
“There is the suspicion, a very well-founded suspicion after all that I have seen, that there has also been fraud,” said Jens Spahn, the country’s Minister of Health, on Tuesday.
The issue has again raised the question of who is responsible for the German government’s spending madness in response to the pandemic.
Over the past year, many candidates seeking government support for businesses affected by the lockdown made fraudulent claims, resulting in tighter rules and serious payment delays as new checks were rolled out. carried out.
This story has been corrected to say that the World Health Organization granted emergency use authorization, not emergency use.